Who We Are

Rick Hiatt

• Global VP of Business Development for Siemens Healthcare’s Molecular Imaging Group
• President United Pharmacy Partners, a network of 50+ independent radiopharmacies
• VP of Business Logistics & Supplier Relations, Syncor International

Jack Coffey

• Previously Sr. VP of Quality & Regulatory for Cardinal Health Nuclear Pharmacy Services
• VP of Quality & Regulatory, Syncor International (now Cardinal Health)

Jamie Singer

• Previously Project Manager at Scientific Project Management, responsible for planning, budgeting and execution of outsourcing, quality assurance and quality control activities in support of regulatory filings
• Scientist at Pfizer Global R&D at Wyeth

Dave Casebier Ph.D.

• Formerly VP of CMC forNavidea Biopharmaceuticals, working on the successful US and EU approval of Lymphoseek and the implementation of commercial supply chain and development of Flutafuranol, NAV4694
• Senior VP at Tokai Pharmaceuticals, responsible for CMC
• Senior Director at BMSMI-Lantheus Medical Imaging, program leader, discovery and development of Flurpiridaz and LMI1195
• VP at ArQule Inc, responsible for foundational technology and creation of the Production and Engineering groups

Dave Smith

• Current owner, CycloSmith LLC
• Radiopharmacy Consultancy and America’s representative for ORA Sprl
• Previously, Director Technical Services, IBA Molecular
• General Manager, UPPI-PET PET Operations
• Senior Support Engineer, Radiopharmacy Americas, GE Healthcare
• Clinical Engineer, Wake Forest Univ.
• Clinical Research Coordinator at The Mayo Clinic and Oregon Health and Science Univ.

Joanna Shuping

Fifteen years in drug and device clinical research including roles of increasing responsibility at:

• Cardinal Health (Sr. Consultant)
• Devicor (SME Consultant)
• Navidea (Director, Clinical Research)
• Wake Forest Health Sciences, CCC and Dept. of Neurology (Project Manager)
• The Segal Institute (Site Director) and
• Piedmont Medical Research (Clinical Research Coordinator)

Claire Wilde

• Formerly Sr. Clinical Data Manager at Ionis Pharmaceuticals
• Project Manager in drug development at Ionis.

Bill Abbott

• Previously in executive roles including VP Operations at Life Molecular Imaging (formally Piramal Imaging)
• President of Jubilant Draximage
• VP and General Manager of Nuclear Medicine at Bracco Diagnostics
• Upper level management positions with DuPont Pharma (now Lantheus Medical Imaging)
• Past Chair of the MITA PET Group industry forum

Stephen Arnold

• Previously, Diector, Finance CTI Molecular Imaging Inc.
• VP Finance AMETEK, Advanced Measurement Technology (NYSE: AME)
• CFO Sensus Healthcare Inc. (NASDAQ: SRTS).
• CFO ProNova Solutions

John Doumitt

• Previously, General Manager and CEO of HemaCare Corporation
• VP of Operations at Activus Medical Solutions
• Sr. Director of Operations Finance at Ingram Micro
• Director of Field Services at Syncor International (now Cardinal Health).

Habibi Mamone

• Previously President and CEO of SSCM, LLC (Supply Chain Management)
• Vice President of Greenbrier (Five Star Resort)
• Director of Logistics at Siemens

Sulantha Mathotaarachchi

• Expertise developing informatics platforms to manage and analyze healthcare data with machine learning
• 5 years of experience on software platforms and analytics in neuroimaging
• Computer Science and Engineering with Masters in Neuroscience from McGill Univ.

Thom Tulip Ph.D.

• Long experience in Medical Imaging Pharmaceuticals
• Held roles of increasing responsibility at DuPont, BMS, Lantheus, Alseres, Navidea (Pres.& COO) and Fluoropharma (Pres. & CEO)
• Established and led the multidisciplinary PET group at MITA (The Medical Imaging Technology Assn.)
• Serves on the Executive Comm. of MITA’s Board of Directors

Bruno Rossi

• Over twenty years of experience in the pharma in Japan and SE Asia with roles of increasing responsibility at Ciba-Geigy, Schering and Bayer in Japan, Switzerland and Singapore
• Developed the early strategy for florbetaben (amyloid PET tracer) and introduced Zevalin and Xofigo (oncology) in Japan
• Leading industry role with EFPIA in connection with the introduction of Health Technology Assessment in Japan
• Currently advising companies with a focus on business development and market access

Mas Tsuno

• Previously Deputy Chief Clinical Officer of Neurology Clinical Development of Eisai
• Over 40 years Pharma R&D experiences based in US, Europe and Japan having held multiple management positions at Eisai including global clinical development (President, Eisai Medical Research Inc.), R&D strategy and planning, pharmacovigilance, post-marketing surveillance.
• Experiences crossing multiple therapeutic areas (neurology, immunology, oncology, gastrointestinal and  cardiovascular)

David Morehous

• Former Senior Counsel and lead global lawyer for Siemens Healthcare’s Molecular Imaging business unit
• Former Assistant General Counsel of CTI Molecular Imaging, through $1 billion acquisition by Siemens Medical Solutions

Paul Graziano

• Over 25 years of experience in the Information Technology business, including business development and high-tech experience with Fortune 500 companies
• Developing innovative technology strategies, with particular expertise in Cloud computing integration and Strategic planning and development for Information Systems